Cargando…

Invasive lobular carcinoma: clinicopathological features and subtypes

OBJECTIVE: To analyze the characteristics of invasive lobular carcinoma (ILC) compared with invasive ductal carcinoma (IDC) and to investigate the impact of histology on axillary lymph node (ALN) involvement in luminal A subtype tumors. METHODS: We retrospectively analyzed patients diagnosed with IL...

Descripción completa

Detalles Bibliográficos
Autores principales: Danzinger, Sabine, Hielscher, Nora, Izsó, Miriam, Metzler, Johanna, Trinkl, Carmen, Pfeifer, Christian, Tendl-Schulz, Kristina, Singer, Christian F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258769/
https://www.ncbi.nlm.nih.gov/pubmed/34187216
http://dx.doi.org/10.1177/03000605211017039
_version_ 1783718558368268288
author Danzinger, Sabine
Hielscher, Nora
Izsó, Miriam
Metzler, Johanna
Trinkl, Carmen
Pfeifer, Christian
Tendl-Schulz, Kristina
Singer, Christian F.
author_facet Danzinger, Sabine
Hielscher, Nora
Izsó, Miriam
Metzler, Johanna
Trinkl, Carmen
Pfeifer, Christian
Tendl-Schulz, Kristina
Singer, Christian F.
author_sort Danzinger, Sabine
collection PubMed
description OBJECTIVE: To analyze the characteristics of invasive lobular carcinoma (ILC) compared with invasive ductal carcinoma (IDC) and to investigate the impact of histology on axillary lymph node (ALN) involvement in luminal A subtype tumors. METHODS: We retrospectively analyzed patients diagnosed with ILC or IDC from 2012 to 2016 who underwent surgery. Patients constituted 493 primary early breast cancer cases (82 ILC; 411 IDC). RESULTS: Compared with IDC, ILC tumors were significantly more likely to be grade 2, estrogen receptor- (ER) positive (+), have a lower proliferation rate (Ki67 <14%), and a higher pathological T stage (pT2–4). The luminal A subtype was significantly more common in ILC compared with IDC. In a multivariate regression model, grade 2, ER+, progesterone receptor-positive, pT2, and pT3 were significantly associated with ILC. Additionally, with the luminal A subtype, ALN involvement (pathological node stage (pN)1–3) was significantly more frequent with ILC versus IDC. CONCLUSIONS: Our data suggest that grade 2, positive hormone receptor status, and higher pathological T stage are associated with ILC. With the luminal A subtype, ALN involvement was more frequent with ILC versus IDC.
format Online
Article
Text
id pubmed-8258769
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-82587692021-07-16 Invasive lobular carcinoma: clinicopathological features and subtypes Danzinger, Sabine Hielscher, Nora Izsó, Miriam Metzler, Johanna Trinkl, Carmen Pfeifer, Christian Tendl-Schulz, Kristina Singer, Christian F. J Int Med Res Retrospective Clinical Research Report OBJECTIVE: To analyze the characteristics of invasive lobular carcinoma (ILC) compared with invasive ductal carcinoma (IDC) and to investigate the impact of histology on axillary lymph node (ALN) involvement in luminal A subtype tumors. METHODS: We retrospectively analyzed patients diagnosed with ILC or IDC from 2012 to 2016 who underwent surgery. Patients constituted 493 primary early breast cancer cases (82 ILC; 411 IDC). RESULTS: Compared with IDC, ILC tumors were significantly more likely to be grade 2, estrogen receptor- (ER) positive (+), have a lower proliferation rate (Ki67 <14%), and a higher pathological T stage (pT2–4). The luminal A subtype was significantly more common in ILC compared with IDC. In a multivariate regression model, grade 2, ER+, progesterone receptor-positive, pT2, and pT3 were significantly associated with ILC. Additionally, with the luminal A subtype, ALN involvement (pathological node stage (pN)1–3) was significantly more frequent with ILC versus IDC. CONCLUSIONS: Our data suggest that grade 2, positive hormone receptor status, and higher pathological T stage are associated with ILC. With the luminal A subtype, ALN involvement was more frequent with ILC versus IDC. SAGE Publications 2021-06-29 /pmc/articles/PMC8258769/ /pubmed/34187216 http://dx.doi.org/10.1177/03000605211017039 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Retrospective Clinical Research Report
Danzinger, Sabine
Hielscher, Nora
Izsó, Miriam
Metzler, Johanna
Trinkl, Carmen
Pfeifer, Christian
Tendl-Schulz, Kristina
Singer, Christian F.
Invasive lobular carcinoma: clinicopathological features and subtypes
title Invasive lobular carcinoma: clinicopathological features and subtypes
title_full Invasive lobular carcinoma: clinicopathological features and subtypes
title_fullStr Invasive lobular carcinoma: clinicopathological features and subtypes
title_full_unstemmed Invasive lobular carcinoma: clinicopathological features and subtypes
title_short Invasive lobular carcinoma: clinicopathological features and subtypes
title_sort invasive lobular carcinoma: clinicopathological features and subtypes
topic Retrospective Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258769/
https://www.ncbi.nlm.nih.gov/pubmed/34187216
http://dx.doi.org/10.1177/03000605211017039
work_keys_str_mv AT danzingersabine invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes
AT hielschernora invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes
AT izsomiriam invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes
AT metzlerjohanna invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes
AT trinklcarmen invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes
AT pfeiferchristian invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes
AT tendlschulzkristina invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes
AT singerchristianf invasivelobularcarcinomaclinicopathologicalfeaturesandsubtypes